Free cash flow remains volatile with margins as low as 2.1% in 2024Q3, while aggressive capital allocation is highlighted by $163.8 million in buybacks during 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 1.91B | 1.86B | 2.07B | 1.27B | 996.02M | 883.7M | 2.36B | 1.44B | 1.34B | 1.18B | 1.29B | 1.02B | 1.04B | 884.24M | 815.27M | 718.25M | 501.34M | 533.3M | 463.1M | 348.5M | 169.24M | 425.43M | 392.88M | 376.77M | 331.26M | 312.19M | 182.45M | 175.6M | 151.7M | 173.5M | 145.3M |
| Operating CF Margin % | - | 10.74% | 13.06% | 8.88% | 7.43% | 6.99% | 20.42% | 12.64% | 12.45% | 11.36% | 13.19% | 11.29% | 12.84% | 12.14% | 11.71% | 9.58% | 9% | 10.25% | 9.22% | 7.34% | 4.04% | 10.81% | 9.98% | 10.34% | 10.16% | 10.99% | 8.14% | 8.6% | 8.09% | 12.03% | 12.21% |
| Operating CF Growth % | -6.03% | -9.81% | 63.05% | 27.29% | 12.71% | -62.56% | 64.08% | 7.28% | 13.39% | -8.22% | 26.21% | -1.45% | 17.15% | 8.46% | 13.51% | 43.27% | -5.99% | 15.16% | 32.89% | 105.92% | -60.22% | 8.28% | 4.27% | 13.74% | 6.11% | 71.1% | 3.9% | 15.75% | -12.56% | 19.41% | 58.45% |
| Net Income | 1.52B | 1.51B | 1.16B | 717.49M | 656.98M | 987.63M | 952.79M | 827.54M | 797.88M | 771.31M | 747.17M | 750.7M | 605M | 554.02M | 489.05M | 448.87M | 275.8M | 304.25M | 199.38M | 170.39M | 259.46M | 240.84M | 169.49M | 199.27M | 175.36M | 99.74M | 93.36M | 77.8M | 79.6M | 67.3M | 50.7M |
| Depreciation & Amortization | 625.82M | 618.74M | 584.83M | 568.04M | 581.86M | 533.21M | 510.49M | 490.39M | 453.08M | 447.88M | 416.61M | 398.62M | 375.62M | 337.36M | 308.69M | 295.86M | 224M | 204.7M | 195.77M | 183.28M | 163.69M | 163.71M | 166.68M | 144.47M | 124.79M | 127.52M | 112.81M | 108.3M | 105.4M | 80.7M | 71.9M |
| Stock-Based Compensation | 72.48M | 95.69M | 99.35M | 87.72M | 85.38M | 73.69M | 65.84M | 69.43M | 66.58M | 56.74M | 48.11M | 39.97M | 31.09M | 27.78M | 22.52M | 18.23M | 16.8M | 13.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 26.05M | 3.32M | 90.09M | 49.52M | 0 | 47.36M | 47.36M | 33.91M | 20.12M | 2.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.5M | 16.2M | 15.7M |
| Other Non-Cash Items | -314.13M | -85.32M | -198.95M | -124.34M | -83.85M | 0 | -109.76M | -97.78M | -76.15M | -79.19M | -129.33M | -130.12M | -91.66M | -93.88M | -75.08M | -452K | -1.99M | -1.35M | 3.54M | -3.72M | -117.71M | -73.93M | 41.62M | -5.15M | 11.12M | 91.27M | 26.67M | 11.7M | -100K | 6.5M | -3M |
| Working Capital Changes | -2.1M | -275.89M | 418.76M | 17.07M | -244.35M | -736.89M | 940.81M | 58.79M | 49.98M | -14.16M | 158.55M | -85.64M | 81.92M | 38.84M | 68.02M | -44.25M | -13.25M | 12.61M | 64.42M | -1.45M | -136.21M | 94.8M | 15.09M | 38.19M | 19.98M | -6.35M | -50.38M | -22.2M | -36.7M | -17.2M | -5.9M |
| Change in Receivables | -223.47M | -317.99M | 67.36M | -182.44M | -258.34M | -8.87M | -145.9M | -42.06M | -42.24M | -24.72M | -87.88M | -45.81M | -105.71M | -49.71M | -71.07M | -134.84M | 22.73M | -1.4M | 22.45M | -93.55M | -93.55M | 12.98M | -29.55M | -10.53M | 1.38M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -996.9M | -1.07B | -911.11M | -763.27M | -647.3M | -914.47M | -802.56M | -688.41M | -813.4M | -624.4M | -1.19B | -912.88M | -832.85M | -383.46M | -789.59M | -285.81M | -2.19B | -382.48M | -296.72M | -449.55M | -278.37M | -46.03M | -319.72M | -480.26M | -195.56M | -416.4M | -251.25M | -82.8M | -269.7M | -165.5M | -279.4M |
| Capital Expenditures | -1.01B | -1.02B | -943.81M | -743.05M | -734M | -855.66M | -734.21M | -663.52M | -811.67M | -609.43M | -1.16B | -912.98M | -822.54M | -371.13M | -891.04M | -323.93M | -239.27M | -379.75M | -354.54M | -339.81M | -341.14M | -241.41M | -230.76M | -224.37M | -200.93M | -152.94M | -113.9M | -99.2M | -286.1M | -180.7M | -274.1M |
| CapEx % of Revenue | 5.7% | 5.85% | 5.96% | 5.2% | 5.48% | 6.77% | 6.35% | 5.83% | 7.53% | 5.85% | 11.83% | 10.1% | 10.2% | 5.1% | 12.8% | 4.32% | 4.3% | 7.3% | 7.06% | 7.15% | 8.14% | 6.13% | 5.86% | 6.16% | 6.17% | 5.38% | 5.08% | 4.86% | 15.26% | 12.53% | 23.03% |
| Acquisitions | -26.24M | -31.94M | -18.72M | -3.73M | -20.31M | -105.31M | -54.78M | -14.58M | -15.23M | -15.08M | -32M | -3.3M | -12M | -12.64M | 0 | -29.47M | -1.96B | -12.5M | -23M | -109.74M | -81.8M | -280.83M | -162.93M | -281.27M | -3M | -263.46M | -141.33M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 44.17M | 28.69M | 51.42M | -16.51M | 12M | 46.51M | 8.07M | -10.31M | 13.5M | 108K | -32M | 3.39M | 1.69M | 307K | 94.95M | 67.59M | 3.49M | 9.77M | 57.81M | 144.57M | 144.57M | 476.21M | 73.97M | 25.38M | 8.37M | 0 | 16.25M | 16.4M | 16.4M | 15.2M | -5.3M |
| Cash from Financing | -880.2M | -749.73M | -1.14B | -493.94M | -318.4M | -1.07B | -384.86M | -845.04M | -492.2M | -519.15M | -125.95M | -77.25M | -187.42M | -507.02M | -43.44M | -420.69M | 1.71B | -147.11M | -177.27M | 102.47M | 116.11M | -404.56M | -74.9M | 120.6M | -140.8M | 116.52M | 73.16M | -87.8M | 119M | -7.9M | 134.4M |
| Debt Issued (Net) | 98.69M | 241.65M | -429.75M | 99.62M | 615.95M | 217.11M | -160.97M | -17.92M | -53.04M | -102.01M | 711.62M | 179M | -49.13M | -424.46M | 55.57M | -307.02M | 1.87B | -40.43M | -15.43M | 174.49M | 459.45M | -149.89M | -36.23M | 161.87M | -67.13M | 143.49M | 111.52M | -600K | 144.1M | -9.5M | 34.1M |
| Equity Issued (Net) | -731.5M | -951.22M | -655.68M | -547.36M | -832.92M | -1.22B | -206.72M | -770.5M | -397.43M | -364.4M | -353.38M | -209.78M | -100.75M | -27.2M | -13.72M | -55.7M | -7.93M | -60M | -147.05M | -71.83M | -344.74M | -235.57M | -20.46M | -51.17M | -73.67M | -5.72M | -30.73M | -68.7M | -23.4M | 1.6M | 100.3M |
| Dividends Paid | -50.71M | -51.27M | -53.35M | -55.48M | -58.45M | -65.9M | -17.34M | -53M | -37.34M | -38.21M | -38.88M | -39.53M | -29.66M | -19.62M | -58.4M | -19.47M | -19.42M | -16.71M | -16.15M | -17.17M | -17.45M | -17.89M | -18.63M | -4.64M | 0 | -14.64M | -7.63M | -18.4M | -1.8M | 0 | 0 |
| Share Repurchases | -908.41M | -967.95M | -670.75M | -547.36M | -832.92M | -1.22B | -206.72M | -770.5M | -397.43M | -364.4M | -353.38M | -209.78M | -100.75M | -27.2M | -19.15M | -60.48M | -11.53M | -63.29M | -149.4M | -74.09M | -350.37M | -249.06M | -23.53M | -54.32M | -76.61M | -7.73M | -35.98M | -71.2M | -24.9M | 0 | 0 |
| Other Financing | -196.69M | 11.11M | -6.09M | 9.28M | -42.99M | 715K | 172K | -3.61M | -4.4M | -14.54M | -27.31M | -6.93M | -7.88M | -35.73M | -26.89M | -38.5M | -133.67M | -29.87M | 1.36M | -588K | 18.83M | -1.22M | 422K | 14.54M | 5.91M | -6.61M | 0 | -100K | 100K | 0 | 0 |
| Net Change in Cash | -990K | 46.57M | 10.28M | 13.63M | 21.9M | -1.1B | 1.17B | -94.02M | 32.39M | 40.68M | -27.48M | 29.16M | 14.83M | -6.23M | -17.76M | 11.76M | 20.29M | 3.72M | -10.89M | 1.42M | 6.98M | -25.16M | -1.74M | 17.11M | -5.1M | 12.3M | 4.36M | 4.9M | 1M | 100K | 300K |
| Free Cash Flow | 894.02M | 849.25M | 1.12B | 524.74M | 262.02M | 28.04M | 1.63B | 774.95M | 529.22M | 573.15M | 133.26M | 107.92M | 213.34M | 513.11M | -75.77M | 394.32M | 262.07M | 153.56M | 108.56M | 8.68M | -171.9M | 184.01M | 162.12M | 152.41M | 130.33M | 159.25M | 68.55M | 76.4M | -134.4M | -7.2M | -128.8M |
| FCF Margin % | 5.03% | 4.89% | 7.1% | 3.67% | 1.96% | 0.22% | 14.07% | 6.81% | 4.91% | 5.51% | 1.36% | 1.19% | 2.65% | 7.04% | -1.09% | 5.26% | 4.71% | 2.95% | 2.16% | 0.18% | -4.1% | 4.68% | 4.12% | 4.18% | 4% | 5.61% | 3.06% | 3.74% | -7.17% | -0.5% | -10.82% |
| FCF Growth % | -15.37% | -24.4% | 114.07% | 100.27% | 834.59% | -98.28% | 109.81% | 46.43% | -7.66% | 330.11% | 23.48% | -49.41% | -58.42% | 777.21% | -119.21% | 50.46% | 70.67% | 41.45% | 1150.44% | 105.05% | -193.42% | 13.5% | 6.37% | 16.94% | -18.16% | 132.3% | -10.27% | 156.85% | -1766.67% | 94.41% | 19.75% |
| FCF per Share | - | 13.17 | 16.54 | 7.48 | 3.55 | 0.33 | 19.00 | 8.70 | 5.65 | 5.95 | 1.35 | 1.07 | 2.12 | 5.16 | -0.78 | 4.00 | 2.67 | 1.56 | 1.07 | 0.08 | -1.48 | 1.47 | 1.25 | 1.17 | 0.97 | 1.18 | 0.53 | 0.60 | -1.01 | -0.05 | -1.05 |
| FCF Conversion (FCF/Net Income) | 0.59x | 1.25x | 1.81x | 1.77x | 1.47x | 0.89x | 2.50x | 1.77x | 1.72x | 1.57x | 1.83x | 1.50x | 1.90x | 1.73x | 1.84x | 1.80x | 2.18x | 2.05x | 2.32x | 2.05x | 0.65x | 1.77x | 2.32x | 1.89x | 1.89x | 3.13x | 1.95x | 2.26x | 1.91x | 2.58x | 2.87x |
| Interest Paid | 75.33M | 0 | 168.27M | 200.45M | 120.14M | 75.61M | 112.6M | 157.41M | 150.29M | 135.53M | 107.08M | 107.05M | 130.28M | 131.26M | 157.41M | 176.33M | 76.9M | 57.02M | 62.28M | 58.57M | 35.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 350.33M | 0 | 325.43M | 257.9M | 250.76M | 362.98M | 286.25M | 260.62M | 293.84M | 370.86M | 344.61M | 380.66M | 258.61M | 259.9M | 264.82M | 163.03M | 152.09M | 155.37M | 130.38M | 93.52M | 263.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Working capital volatility
According to recent financial disclosures, UHS exhibits a volatile relationship between net income and operating cash flow, with the OCF/NI ratio fluctuating from a high of 2.35 in 2024Q2 to a low of 1.02 in 2025Q3, suggesting inconsistent cash conversion efficiency across different reporting periods.
The significant variance in the OCF/NI ratio implies that reported net income is frequently decoupled from actual cash generation, likely due to the timing of collections and accruals. Investors should monitor whether this divergence stems from structural delays in government reimbursement or temporary shifts in working capital management.
As reported in quarterly filings, FCF margins have demonstrated significant instability, ranging from a peak of 11.2% in 2024Q2 to a trough of 2.1% in 2024Q3, indicating that the company's ability to convert revenue into discretionary cash remains highly sensitive to operational and capital expenditure cycles.
The erratic FCF trajectory suggests that UHS faces difficulty in maintaining consistent cash flow generation despite steady top-line growth. This volatility may indicate that capital-intensive maintenance requirements or lumpy investment cycles are periodically suppressing the company's ability to generate meaningful free cash flow for shareholders.
Based on reported figures, UHS maintains a consistent capital intensity with CapEx/Revenue ratios hovering between 4.8% and 6.3%, reflecting the ongoing necessity of reinvesting in facility infrastructure to support its specialized behavioral and acute care networks across diverse geographic markets.
The steady level of capital expenditure suggests that the company is prioritizing the maintenance and modernization of its existing footprint to preserve its competitive moat. However, the lack of a clear downward trend in capital intensity implies that the business model remains inherently asset-heavy and capital-hungry.
Data from recent cash flow statements highlights significant swings in working capital, with changes ranging from a $210.9 million inflow in 2024Q2 to a $130.5 million outflow in 2024Q4, suggesting that the company's cash cycle is subject to substantial, unpredictable fluctuations in accounts receivable and payable management.
These sharp reversals in working capital suggest that UHS may be experiencing inconsistent collection cycles, potentially tied to the complexity of payer mix and government reimbursement timelines. Such instability warrants further investigation into whether these shifts represent structural inefficiencies in the revenue cycle management process.
As evidenced by recent financial statements, UHS consistently prioritizes share repurchases, with buybacks totaling $163.8 million in 2026Q1 alone, which often exceeds the company's quarterly free cash flow, indicating a reliance on balance sheet liquidity to fund shareholder returns rather than relying solely on organic cash generation.
The company's commitment to aggressive share repurchases, even during periods of lower FCF, suggests a management preference for returning capital to shareholders. Investors should monitor whether this pace of buybacks remains sustainable if operational cash flow continues to exhibit the volatility observed in recent quarters.
Quick answers to the most common questions about buying UHS stock.
Universal Health Services, Inc. (UHS) generated $1.86B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Universal Health Services, Inc. (UHS) generated $849.2M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Universal Health Services, Inc. (UHS) spent $1.02B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Universal Health Services, Inc. (UHS) returned $51.3M to shareholders via cash dividends and spent $968.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.